Skip to content
The Nexus
HEALTHMay 28 · 19:08 UTCMARKETWATCHJaimy Lee

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

CVS will cover Lilly’s GLP-1 medications, Foundayo (a pill) and Zepbound (an injection), potentially expanding access for millions of Americans.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
LillyorganizationCVSorganizationFoundayoproductZepboundproductGLP-1 medicationstopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting